Translational studies of adrenomedullin and related peptides regarding cardiovascular diseases
Authors:
- 6 January 2022
- journal article
- review article
- Published by Springer Nature in Hypertension Research
- Vol. 45 (3) , 389-400
Abstract
Adrenomedullin (AM) is a vasodilative peptide with various physiological functions, including the maintenance of vascular tone and endothelial barrier function. AM levels are markedly increased during severe inflammation, such as that associated with sepsis; thus, AM is expected to be a useful clinical marker and therapeutic agent for inflammation. However, as the increase in AM levels in cardiovascular diseases (CVDs) is relatively low compared to that in infectious diseases, the value of AM as a marker of CVDs seems to be less important. Limitations pertaining to the administrative route and short half-life of AM in the bloodstream (<30 min) restrict the therapeutic applications of AM for CVDs. In early human studies, various applications of AM for CVDs were attempted, including for heart failure, myocardial infarction, pulmonary hypertension, and peripheral artery disease; however, none achieved success. We have developed AM as a therapeutic agent for inflammatory bowel disease in which the vasodilatory effect of AM is minimized. A clinical trial evaluating this AM formulation for acute cerebral infarction is ongoing. We have also developed AM derivatives that exhibit a longer half-life and less vasodilative activity. These AM derivatives can be administered by subcutaneous injection at long-term intervals. Accordingly, these derivatives will reduce the inconvenience in use compared to that for native AM and expand the possible applications of AM for treating CVDs. In this review, we present the latest translational status of AM and its derivatives.Keywords
This publication has 147 references indexed in Scilit:
- Angiogenic and Vasoprotective Effects of Adrenomedullin on Prevention of Cognitive Decline After Chronic Cerebral Hypoperfusion in MiceStroke, 2011
- Calcitonin receptor-like receptor: identification and distribution in human peripheral tissuesCell and tissue research, 2002
- The adrenomedullin receptor acts as clearance receptor in pulmonary circulationBiochemical and Biophysical Research Communications, 2002
- The Intermediate Form of Glycine-Extended Adrenomedullin Is the Major Circulating Molecular Form in Human PlasmaBiochemical and Biophysical Research Communications, 1998
- Amylin, Calcitonin Gene-Related Peptide, Calcitonin, and Adrenomedullin: A Peptide SuperfamilyCritical Reviews™ in Neurobiology, 1997
- Inhibition of Aldosterone Production by Adrenomedullin, a Hypotensive Peptide, in the RatHypertension, 1996
- Inhibition of Endothelin Production by Adrenomedullin in Vascular Smooth Muscle CellsHypertension, 1995
- Genomic Structure of Human Adrenomedullin GeneBiochemical and Biophysical Research Communications, 1994
- Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasmaFEBS Letters, 1994
- Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human PheochromocytomaBiochemical and Biophysical Research Communications, 1993